
Harry Abraham Seifert MD MSCE, FISPE
Clinical Pharmacology
Physician
Join to View Full Profile
428 Holly LnWynnewood, PA 19096
Phone+1 610-716-3077
Dr. Seifert is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Harry Seifert is an physician epidemiologist based in Wynnewood, PA, with subspecialty expertise in pharmacovigilance. He graduated from the Lewis Katz School of Medicine at Temple University in 1985. Dr. Seifert has experience in anesthesiology, clinical epidemiology, vaccines, drug toxicity, and pharmacoepidemiology. His research includes work on the surgical outcomes, and studies on post-marketing safety surveillance. His work has been published in journals like Drug Safety and the American Heart Journal, and cited multiple times.
Education & Training
- Perelman School of Medicine at the University of PennsylvaniaMSCE, Clinical Epidemiology, 1997 - 1999
- University of ConnecticutResidency, Anesthesiology, 1986 - 1990
- Lewis Katz School of Medicine at Temple UniversityClass of 1985
Certifications & Licensure
- PA State Medical License 1993 - 2026
- CT State Medical License 1990 - 1994
- American Board of Anesthesiology Anesthesiology
Publications & Presentations
PubMed
- Risk of incident gout following exposure to recombinant zoster vaccine in US adults aged ≥50 years.Sheryl A Kluberg, Andrew L Simon, Sarah M Alam, Alexander Peters, Casie Horgan
Seminars in Arthritis and Rheumatism. 2024-10-01 - Risk of incident gout following exposure to recombinant zoster vaccine in US adults aged ≥65 years.Chengchen Zhang, Alejandro Amill-Rosario, Abree Johnson, Haeyoung Lee, O'Mareen Spence
Seminars in Arthritis and Rheumatism. 2024-10-01 - 2 citationsPost-Marketing Safety Surveillance for the Adjuvanted Recombinant Zoster Vaccine: MethodologyFernanda Tavares-Da-Silva, Olivia Mahaux, Lionel Van Holle, François Haguinet, Harry A. Seifert
Drug Safety. 2020-12-01
Professional Memberships
- International Society of PharmacoepidemiologyFellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: